Global Oligonucleotide Synthesis Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Oligonucleotide Synthesis Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Synthesized Oligonucleotides
  • 1.4.3 Reagents
  • 1.4.4 Equipment
• 1.5 Market by Application
  • 1.5.1 Global Oligonucleotide Synthesis Market Share by Application (2014-2025)
  • 1.5.2 PCR
  • 1.5.3 DNA
  • 1.5.4 RNAi
  • 1.5.5 Research
  • 1.5.6 Therapeutic
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Oligonucleotide Synthesis Market Size
• 2.2 Oligonucleotide Synthesis Growth Trends by Regions
  • 2.2.1 Oligonucleotide Synthesis Market Size by Regions (2014-2025)
  • 2.2.2 Oligonucleotide Synthesis Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Oligonucleotide Synthesis Market Size by Manufacturers
  • 3.1.1 Global Oligonucleotide Synthesis Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Oligonucleotide Synthesis Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
• 3.2 Oligonucleotide Synthesis Key Players Head office and Area Served
• 3.3 Key Players Oligonucleotide Synthesis Product/Solution/Service
• 3.4 Date of Enter into Oligonucleotide Synthesis Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Oligonucleotide Synthesis Market Size by Type (2014-2019)
• 4.2 Global Oligonucleotide Synthesis Market Size by Application (2014-2019)

5 United States

• 5.1 United States Oligonucleotide Synthesis Market Size (2014-2019)
• 5.2 Oligonucleotide Synthesis Key Players in United States
• 5.3 United States Oligonucleotide Synthesis Market Size by Type
• 5.4 United States Oligonucleotide Synthesis Market Size by Application

6 Europe

• 6.1 Europe Oligonucleotide Synthesis Market Size (2014-2019)
• 6.2 Oligonucleotide Synthesis Key Players in Europe
• 6.3 Europe Oligonucleotide Synthesis Market Size by Type
• 6.4 Europe Oligonucleotide Synthesis Market Size by Application

7 China

• 7.1 China Oligonucleotide Synthesis Market Size (2014-2019)
• 7.2 Oligonucleotide Synthesis Key Players in China
• 7.3 China Oligonucleotide Synthesis Market Size by Type
• 7.4 China Oligonucleotide Synthesis Market Size by Application

8 Japan

• 8.1 Japan Oligonucleotide Synthesis Market Size (2014-2019)
• 8.2 Oligonucleotide Synthesis Key Players in Japan
• 8.3 Japan Oligonucleotide Synthesis Market Size by Type
• 8.4 Japan Oligonucleotide Synthesis Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Oligonucleotide Synthesis Market Size (2014-2019)
• 9.2 Oligonucleotide Synthesis Key Players in Southeast Asia
• 9.3 Southeast Asia Oligonucleotide Synthesis Market Size by Type
• 9.4 Southeast Asia Oligonucleotide Synthesis Market Size by Application

10 India

• 10.1 India Oligonucleotide Synthesis Market Size (2014-2019)
• 10.2 Oligonucleotide Synthesis Key Players in India
• 10.3 India Oligonucleotide Synthesis Market Size by Type
• 10.4 India Oligonucleotide Synthesis Market Size by Application

11 Central & South America

• 11.1 Central & South America Oligonucleotide Synthesis Market Size (2014-2019)
• 11.2 Oligonucleotide Synthesis Key Players in Central & South America
• 11.3 Central & South America Oligonucleotide Synthesis Market Size by Type
• 11.4 Central & South America Oligonucleotide Synthesis Market Size by Application

12 International Players Profiles

• 12.1 Integrated DNA Technologies
  • 12.1.1 Integrated DNA Technologies Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Oligonucleotide Synthesis Introduction
  • 12.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2014-2019)
  • 12.1.5 Integrated DNA Technologies Recent Development
• 12.2 Merck KGaA
  • 12.2.1 Merck KGaA Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Oligonucleotide Synthesis Introduction
  • 12.2.4 Merck KGaA Revenue in Oligonucleotide Synthesis Business (2014-2019)
  • 12.2.5 Merck KGaA Recent Development
• 12.3 Eurofins Genomics
  • 12.3.1 Eurofins Genomics Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Oligonucleotide Synthesis Introduction
  • 12.3.4 Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2014-2019)
  • 12.3.5 Eurofins Genomics Recent Development
• 12.4 Thermo Fisher Scientific
  • 12.4.1 Thermo Fisher Scientific Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Oligonucleotide Synthesis Introduction
  • 12.4.4 Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2014-2019)
  • 12.4.5 Thermo Fisher Scientific Recent Development
• 12.5 Bioautomation
  • 12.5.1 Bioautomation Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Oligonucleotide Synthesis Introduction
  • 12.5.4 Bioautomation Revenue in Oligonucleotide Synthesis Business (2014-2019)
  • 12.5.5 Bioautomation Recent Development
• 12.6 Agilent Technologies
  • 12.6.1 Agilent Technologies Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Oligonucleotide Synthesis Introduction
  • 12.6.4 Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2014-2019)
  • 12.6.5 Agilent Technologies Recent Development
• 12.7 Eurogentec
  • 12.7.1 Eurogentec Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Oligonucleotide Synthesis Introduction
  • 12.7.4 Eurogentec Revenue in Oligonucleotide Synthesis Business (2014-2019)
  • 12.7.5 Eurogentec Recent Development
• 12.8 GE Healthcare
  • 12.8.1 GE Healthcare Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Oligonucleotide Synthesis Introduction
  • 12.8.4 GE Healthcare Revenue in Oligonucleotide Synthesis Business (2014-2019)
  • 12.8.5 GE Healthcare Recent Development
• 12.9 LGC Biosearch Technologies
  • 12.9.1 LGC Biosearch Technologies Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Oligonucleotide Synthesis Introduction
  • 12.9.4 LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2014-2019)
  • 12.9.5 LGC Biosearch Technologies Recent Development
• 12.10 Nitto Denko Avecia
  • 12.10.1 Nitto Denko Avecia Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Oligonucleotide Synthesis Introduction
  • 12.10.4 Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2014-2019)
  • 12.10.5 Nitto Denko Avecia Recent Development
• 12.11 Genscript
• 12.12 Genedesign
• 12.13 TriLink Biotechnologies
• 12.14 Bio-Synthesis
• 12.15 ATDBio

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer